Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Clear Secure Inc. (NASDAQ: YOU) Chief Executive Officer Caryn Seidman Becker completed a significant divestment of 100,757 Class A common shares, realizing approximately $5.38 million in proceeds. The transaction, executed on July 13, 2026, was part of a Rule 10b5-1 trading plan established in March 2026. This sale follows a period of robust stock …
Alclear Investments, LLC, a key shareholder and director of Clear Secure, Inc. (NASDAQ: YOU), executed a significant sale of Class A common stock totaling approximately $5.38 million on July 13, 2026. The transaction, conducted under a pre-existing Rule 10b5-1 trading plan, involved the liquidation of 100,757 shares at prices ranging from $53.00 to…
Thrivent Financial for Lutherans, a notable shareholder in Gloo Holdings, Inc. (GLOO), executed a series of sales involving 190,000 shares of Class A Common Stock between July 13 and July 15, 2026. The divestment, totaling $634,838 in aggregate value, occurred while the stock traded around $3.36, marking a significant 58% decline over the previous …
Sheena Jonathan, co-founder and director at Natera Inc., liquidated $836,898 worth of Natera common stock on July 13, 2026. The transaction involved the sale of 3,150 shares priced between $262.716 and $268.387 per share. This activity was executed under a Rule 10b5-1 plan established on December 12, 2025. Following the sale, Jonathan retains direc…
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Chief Medical Officer Rodman David Malcom executed two separate sales of company common stock totaling $556,671 on July 13 and July 15, 2026. The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan established on October 6, 2025. Concurrently with the initial sale on July 13, Mr. Malc…
Mineralys Therapeutics, Inc. (NASDAQ:MLYS) CEO Jon Congleton executed a sale of 10,700 shares of the company's common stock on July 13, 2026, totaling $291,441. The transaction, conducted through a Rule 10b5-1 trading plan adopted in January 2025, saw shares sold at prices between $26.80 and $27.58. This sale reduces Congleton's direct holdings but…
CrowdStrike CEO George Kurtz sold 20,000 shares in mid-July 2026, following a 10b5-1 plan adopted in January. The sale occurs as the stock approaches its 52-week high of $217.50, with recent analyst upgrades and a new Chief Product Officer appointment highlighting ongoing strategic developments within the cybersecurity firm.
Denis O'Leary, a director at CrowdStrike Holdings, Inc. (NASDAQ: CRWD), executed a transaction involving the sale of 14,500 shares of the company's Class A common stock, resulting in proceeds of approximately $2.72 million. The sale, facilitated through a charitable remainder trust on July 13, 2026, occurred at prices between $187.72 and $188.12 pe…
CoreWeave, Inc. (NASDAQ:CRWV) Chief Development Officer McBee Brannin executed a significant divestment of company equity on July 13, 2026, selling 53,000 Class A Common Stock shares. The transaction, valued at approximately $4.49 million, was facilitated through a pre-arranged Rule 10b5-1 trading plan established in March 2026. This sale occurred …
Javier Olivan, Chief Operating Officer of Meta Platforms, Inc., executed a series of stock sales totaling $1,429,787 on July 13, 2026. The transactions involved the disposal of Class A Common Stock through both direct holdings and various indirect entities managed by Mr. Olivan and his spouse. All sales were conducted under a Rule 10b5-1 trading pl…
CoreWeave, Inc. (NASDAQ: CRWV) Chief Financial Officer Nitin Agrawal executed a significant sale of company equity on July 13, 2026, divesting $5,512,785 worth of Class A Common Stock. The transactions were facilitated through a Rule 10b5-1 trading plan, a mechanism designed to allow executives to buy or sell shares at predetermined times regardles…
Qualys, Inc. (NASDAQ:QLYS) CEO and President Sumedh S. Thakar executed a sale of 3,200 shares on July 14, 2026, generating approximately $513,610. The transaction was conducted under a Rule 10b5-1 trading plan established in February 2026. Following the sale, Thakar retains direct ownership of 193,486 shares. The executive move coincides with a per…
Intuitive Machines, Inc. (NASDAQ:LUNR) director Kamal Ghaffarian, who holds a significant 10% stake in the firm, executed a substantial divestment of his holdings on July 13, 2026. The transaction involved the sale of 110,976 Class A Common Stock shares, generating approximately $1.74 million in proceeds. This divestment occurred against a backdrop…
Kevin Tang, a major shareholder in Fulcrum Therapeutics, Inc. (NASDAQ: FULC), has executed a series of substantial purchases of the company's common stock. The acquisitions, totaling approximately $891,067, were conducted through Tang Capital Management LLC and its affiliated entities between July 13 and July 15, 2026. This insider buying activity …
Oruka Therapeutics Inc. (NASDAQ: ORKA) Chief Medical Officer Joana Goncalves executed a series of share sales totaling approximately $603,937 on July 15, 2026. The transactions were conducted under a pre-established Rule 10b5-1 trading plan initiated in September 2025. These sales followed the exercise of derivative securities, including employee s…
MediaAlpha, Inc. (NASDAQ:MAX) director Eugene Nonko executed a series of share sales totaling $645,776 between July 13 and July 15, 2026. The transactions involved both direct holdings and indirect ownership through O.N.E. Holdings, LLC, with share prices fluctuating between $13.41 and $14.31. These sales were facilitated under a pre-existing Rule …
MediaAlpha Inc. (NASDAQ: MAX) Chief Executive Officer Steven Yi sold approximately $2.28 million worth of the company's Class A Common Stock over three consecutive days in mid-July. The transactions, executed under a Rule 10b5-1 trading plan established to cover tax obligations from restricted stock unit vesting, occur as the stock trades near its …
Keith Cramer, the Chief Revenue Officer at MediaAlpha, Inc. (NASDAQ:MAX), executed a sale of 13,000 shares of the company’s Class A Common Stock on July 15, 2026. The transaction, valued at $184,494, was conducted under a pre-arranged Rule 10b5-1 trading plan. The sale price per share ranged from $13.87 to $14.31, with a weighted average of $14.191…
Kyle Clark, President and CEO of BETA Technologies, Inc. (BETA), sold $810,337 worth of Class A common stock through The Godric’s Hollow Trust between July 13 and July 15, 2026. The transactions, executed under a 10b5-1 trading plan, occurred as the stock trades at $18.53, reflecting a 48% decline over the past year despite 73% revenue growth. Whil…
Benjamin Silbermann, serving as both a Director and a significant 10% shareholder of Pinterest, Inc. (NASDAQ:PINS), has executed a substantial liquidation of company equity. According to recent Securities and Exchange Commission (SEC) documentation, Silbermann sold a total of 93,750 shares of Pinterest’s Class A Common Stock. This transaction resul…
Pinterest director Rajaram Gokul sold $23,992 worth of Class A Common Stock on July 15, 2026, through a pre-arranged trading plan. The sale involved 1,050 shares at $22.85 per share, executed under a Rule 10b5-1 plan adopted in November 2025. Following the transaction, Gokul retains 38,296 directly held shares, including restricted stock units, and…
Stephanie Lepori, a director at DiamondRock Hospitality Co (NYSE:DRH), has acquired $5,580 in common stock through a series of transactions executed via a broker-administered dividend reinvestment plan. The purchases, which spanned from October 2025 to July 2026, occurred at varying price points between $7.51 and $12.08 per share. Lepori has since …
Core Scientific, Inc. (NASDAQ: CORZ) reported a recent insider sale of 10,000 shares by Chief Legal and Administrative Officer Todd M. DuChene, executed through a Rule 10b5-1 trading plan. The transaction, valued at $224,474, occurs against a backdrop of a 65% stock appreciation over the past year and ongoing corporate developments, including analy…
Joseph Gebbia, a director and significant shareholder in Airbnb, Inc. (NASDAQ: ABNB), completed a substantial divestment of 265,000 shares on July 13, 2026. The transaction, valued at approximately $38.5 million, was executed through a pre-arranged trading plan. This sale occurs amid a broader landscape of analyst adjustments to Airbnb's price targ…
William Glenn, Senior Vice President and President of Europe at Greenbrier Companies Inc (NYSE:GBX), executed significant stock transactions in mid-July 2026, including the sale of common stock and the disposal of phantom shares. This insider activity follows the company's release of fiscal third-quarter 2026 earnings, which revealed a revenue miss…
